The presentation will be webcast live and available for replay in the Investors section of OPKO Health’s website here.
About
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
LHA Investor Relations
ybriggs@lhai.com
or
bvoss@lhai.com
Source:
2024 GlobeNewswire, Inc., source